Alcoholism is a disease characterised by continuous heavy drinking. Until people with alcohol use disorder admit to problems with alcohol and stop drinking, the risk of alcohol use disorder continues which affects both physical and mental health.
Alcohol starts to injure the brain once it reaches the bloodstream.
Excessive consumption can lead to Alcohol-Related Brain Damage, or ARBD, which is a type of brain disorder caused by alcohol consumption. Brain shrinkage caused by alcohol abuse is permanent, as alcohol kills brain cells and grey matter.
For more information and effects click ‘Learn More’.
Family Recovery Compass is a newsletter for friends and family members who feel trapped between supporting a loved one in addiction, and protecting their own wellbeing.
Every week, we tackle one specific situation in addiction family dynamics, and deliver practical decision-making frameworks and exact dialogue scripts – that help you respond with confidence instead of reaction.
Every month, we bring you an unfiltered recovery conversation with someone who’s either experienced addiction firsthand, or works closely with those in recovery.
No sanitised success stories – just practical insights on what actually works in recovery, that you can apply, in your life too.
Recovery capital is the internal and external resource used to begin the recovery process and maintain sobriety. This combines personal, social, and community support to provide a joined-up approach that supports the addict through recovery.
Do you or a loved one need addiction treatment for alcohol or drugs? Thousands blindly walk into addiction treatment in expensive rehab centres and find that the reality doesn’t meet expectations.
If you’re considering rehab treatment, first check our ultimate guide for complete instructions on how to find the right rehab centre for you.
Take-home Naloxone kits help families and loved ones respond quickly in an opioid overdose emergency, until emergency services arrive. Kits contain nasal or injectable forms of Naloxone.
Changes in legislation mean Naloxone kits are now more widely available from pharmacies and drug services, including Abbeycare.
For additional information, click ‘Learn More’ below.
Overcoming alcohol addiction means first ceasing alcohol intake, and taking care of physical and chemical withdrawal symptoms.
Detoxing from alcohol means undergoing withdrawal from alcohol, but with the assistance of prescribed medication and detox phase, to substitute in place of the alcohol itself.
Alcohol rehab focuses on tackling the problems underneath alcoholism, such as grief, trauma, depression, and emotional difficulties, in order to reduce continuing drinking after treatment.
Inpatient services at an alcohol rehab programme provides 24 hour access to specialist care.
Alcohol home detox provides a means of semi-supervised addiction treatment in the comfort of your home. It’s often suitable for those with inescapable practical commitments, or where a reduced budget for treatment is available.
An at-home detox is the most basic detox option available from Abbeycare, and assumes you have support available, post-detox, for the other important elements of long-term addiction recovery.
The term alcoholism refers to the consumption of alcohol to the extent that the person is unable to manage their own drinking habits or patterns, resulting in side-effects that are detrimental to the quality of life and health of the alcoholic, or those around them.
An alcoholic is someone who continues to compulsively abuse alcohol in this way, despite the negative consequences to their lives and health.
Immediately following treatment, the early stages of recovery and abstinence are most vulnerable to lapses.
At Abbeycare, a structured and peer-reviewed aftercare plan is usually prepared whilst still in treatment. This comprises social, peer, and therapeutic resources individuals draw upon, following a residential treatment programme for drug or alcohol misuse.
Clinically managed residential detoxification is:
– A structured detox that uses medication-assisted treatment and regular physical health observations
– Takes place in an inpatient rehabilitation unit or hospital
– Typically lasts from 7-10 days, but in Abbeycare, it is incorporated into a 28-day rehab programme
Cognitive Behavioural Therapy is a well-known therapy option used by doctors at drug and alcohol treatment facilities for the treatment of substance use disorders.
It is a form of talking therapy that helps one mange their problems by changing how they think and behave. This form of therapy is used to treat depression and anxiety and is useful for physical health problems as well as one’s mental health.
Family Therapy at Abbeycare Scotland or Gloucester is realistic, compassionate, and appropriate for families and loved ones of addicts.
Family therapeutic interventions in residential rehabilitation have been designed to support those living with or caring for participants entering the Abbeycare Programme.
Support for families in a group setting allows for a safe, constructive, and confidential place to listen and share common experiences.
Inpatient rehab is drug and/ or alcohol treatment in a rehab centre, where patients remain on-site for the duration of inpatient rehabilitation.
It includes detoxification from drugs, therapy (group work and 1-2-1 sessions), and aftercare planning. Inpatient rehabs typically last 28 days, but this varies on an individual basis.
Long-term treatment at Abbeycare has been developed for those suffering from alcohol or drug addiction. Completing a long-term drug and alcohol inpatient programme may be the solution to problematic substance use.
Motivational Enhancement Therapy can be used by trained addiction recovery therapists to elicit internal changes within and promote long-term recovery from substance use disorder.
All the answers to addiction can be found within with this comprehensive and successful therapy concept leads to behavioural changes, reflective listening, self-motivational statements, and a comprehensive recovery process.
Outpatient drug or alcohol rehab is daytime treatment as opposed to living in a treatment facility.
Outpatient treatment is similar to inpatient in terms of the methods used to treat substance abuse. Where they differ is in their approach to recovery.
Abbeycare’s prison to rehab is a 12-week structured rehab programme which involves direct transfer from prison. The suitability of the candidate is decided by prison staff.
Short-term residential treatment programmes are the chance to press the reset button and access a therapeutic programme designed to create recovery from the use of alcohol and drugs.
Feeling stuck in a rut. Want to stop but can’t seem to achieve sobriety?
Click below.
The 12-step programme was created by alcoholics anonymous (AA), and is specifically designed to aid addicts in achieving and maintaining abstinence.
The central ethos behind the programme is that participants must admit and surrender to a divine power to live happy lives. Ideas and experiences are shared in meetings, and help is sought in an attempt to achieve abstinence.
Abbeycare’s policy to respect your privacy and comply with any applicable law and regulation regarding any personal information we may collect about you, including across our website and other sites we own and operate.
A diagnosis of Hallucinogen Use Disorder, if ≥ 3 symptoms are present, including taking higher LSD doses after being unable to get a “trip”, as stated by the DSM-IV [32][35]
Panic attacks and dysphoria within 24 hours of last use due to impaired 5-HT2A receptor signalling in the prefrontal cortex [12][32]
Physical Indicators Of LSD Addiction
Dilated Pupils
Dilated pupils are a physical indicator of LSD addiction caused by the overactivation of the sympathetic nervous system in the midbrain, resulting in a 16% increase in pupil size (5.8 - 6.7mm) for up to 11 hours after consuming 200 µg of LSD [1].
In a study by Al-Imam (2017), an 18-year-old girl had continuously dilated pupils with a thin rim of blue iridial tissue in both eyes after abusing LSD for 7 years, claiming, “My eyes always look like this, I have constantly dilated pupils, haha, not even tripping.”:
She was instructed to wear UV sunglasses by a specialist optometrist after experiencing discomfort and an occasional burning sensation in the eyes when outdoors, due to the retinas being overexposed to sunlight
She experienced a paradoxical reaction of pupillary constriction due to regular consumption of opioids alongside LSD, claiming, “I do take tramadol and codeine as well, but they do the opposite to my eyes.” [2]
In study by Klock et al. (1975), a 19-year-old had widely dilated pupils (7mm) that were unresponsive to light after crushing and snorting 208mg of LSD tablets with friends, alongside an elevated heart rate (200 bpm) and body temperature (41.6°C) due to sympathetic overactivity [3].
Goosebumps
Goosebumps are a physical indicator of LSD addiction caused by a 2-fold increase in serotonin 2a receptor (5-HT2A) activity lasting up to 96 hours after use, causing body hairs to stand on end (piloerection) due to impaired thermoregulation and autonomic arousal [4].
In a study by Blum et al. (1967), a male LSD user reported having to wear a coat within 30 minutes of consuming 100µg of LSD after “Having a peculiar feeling of chills that was not shared by others” and claiming to shiver as “An icy wind began to blow over and through me” [5].
Frequent goosebumps (>3 times daily) are exacerbated by a 50 pg/mL increase in circulating oxytocin within 3 hours of taking 200µg LSD due to the release of adrenaline triggered by up to 12 hours of emotional arousal, leading to an “all-consuming pleasure” [1][5].
Hallucinogen Persisting Perception Disorder
Hallucinogen Persisting Perception Disorder (HPPD) is a physical indicator of LSD addiction caused by a 7-36% reduction in 5-HT2A signalling in the prefrontal cortex, striatum, and anterior cingulate cortex within 21 months of heavy use (e.g. up to 450 times), leading to persistent visual disturbances, including [6][12]:
Sober flashbacks of visual hallucinations that were experienced whilst intoxicated with up to 88% claiming that symptoms (e.g. seeing ‘halos’ around objects/people) are 5 times more severe after LSD cessation compared to before the ‘triggering event’ [9]
Macropsia, micropsia, flickering when looking at patterned objects, and ‘a glow-worm effect’ that involves seeing bright spots of light across the visual field after taking around thirty 100 μg LSD ‘tabs’ within 1 year [7]
Red objects surrounded by a ‘green shimmer’ like 3-D glasses, people’s faces changing shape, words moving on a page whilst reading, and vehicles appearing to stretch when driving after consuming LSD around 15 times in 6 months [8]
In a study by Hermle et al. (2012), a woman was diagnosed with HPPD after experiencing persistent visual disturbances within 3 weeks of last using LSD, claiming to be unable to distinguish between ‘normal’ and ‘abnormal’ perceptions in everyday life after 1 year of recreational use [7].
Hyperreflexia
Hyperreflexia is a physical indicator of LSD addiction caused by serotonergic overstimulation in the brain, spinal cord, and motor pathways, leading to:
Neuronal excitability and up to 2 – 3 days of 'jumping’ legs and convulsions during attempts at motor movement (e.g. walking), although up to 17% of LSD users experience compulsive movements/actions for over 3 years [10][11]
Exaggerated monosynaptic reflexes (e.g. knee-jerk response) and temperature dysregulation (e.g. hypothermia = <35°C or hyperthermia = >38.0°C) due to a hyperactive autonomic nervous system, as some users claim to be “sweating cold” whilst experiencing “muscle jerks” [10]
In a study by Zafar et al. (2023), an LSD user had muscle spasms in the lower limbs for around 3 hours after consuming 100 µg of LSD, claiming that “I have spasms, my legs did not stop moving” as a result of upper motor neuron dysfunction [10].
Psychological Indicators Of LSD Addiction
Difficulty Differentiating Reality From Hallucinations
Difficulty differentiating reality from hallucinations is a psychological indicator of LSD dependence because chronic use (e.g. up to 450 uses of LSD) leads to the misinterpretation of sensory data (e.g. hearing a song) due to disrupted 5-HT2A signalling in the prefrontal cortex [6].
30% of LSD users develop severe dissociation (DES score >20) with flashback episodes upon awakening, claiming to “Have a fear of going crazy/hearing voices/seeing things that aren’t there” and searching for sources to confirm suspicions (e.g. a beeping watch under clothes) [9].
In a study by Noushad et al. (2015), a frequent LSD user (15 times in 6 months) struggled to distinguish between real and fake visual perceptions, felt that “objects and experiences had a dream-like quality” the day after a 12-hour 'trip', and explained “It’s like drinking alcohol, waking up drunk, and being drunk from that point on” [8].
In a study by Hermle et al. (2012), a 33-year-old experienced depersonalisation/derealisation after consuming LSD 2 – 3 times a month for a year and became suicidal after being unable to differentiate between real and hallucinatory events, although symptoms subsided within 1 year of taking 200mg of lamotrigine daily [7].
Mood Swings
Mood swings are a psychological indicator of LSD dependence caused by disruptions in 5-HT2A receptor signalling in the prefrontal cortex (e.g. reduced by 36% after 5 days of daily use but increases by 2-fold within 2 hours of using again), leading to [4][12]:
Abrupt mood changes in response to a perceptual stimulus (e.g. a sound of a ringing phone), as some users go from speaking with ‘great enthusiasm’ about the “luminous quality” of objects to a state of self-condemnation about 3 hours into drug taking [5]
Extreme pleasure with fits of uncontrollable laughter within 40 minutes of taking 250 µg LSD to extreme anxiety and hostility within 6 hours of use, resulting in feelings of confusion whilst perceiving strangers as threatening [5]
Evans et al. (2023) found that 67% of LSD users had emotional dysregulation after feeling ‘intense euphoria’ for up to 12 hours during a ‘trip’:
“I felt really down afterwards, disempowered within myself, unsure and uncertain of myself, lack of confidence.”
“I fell further into the abyss of hopelessness and despair. I went through the motions of existing. This lasted 2 months.”
“For about 18 months, I awoke with the sun every morning full of absolute terror; sometimes my anxiety would be so high that I would physically shake from the energy.” [11]
Fixation On Experiencing Spiritual Or Mystical Emotional States
A fixation on experiencing self-transcendence is a psychological indicator of LSD dependence because up to 73% continue to use 1 – 2 ‘tabs’ per session for spiritual, psychological, or personal self-exploration in an attempt to replicate a ‘transforming’ experience of a religious or mystical nature [13][14]:
"I felt I was there with God on the day of the Creation. I knew then that there were dimensions to life which had been for me unseen. I swore I would never be blind to its enchantment again." [5]
He felt an "extreme contentment" and like he had been "reborn and moved far beyond the limits imposed on the old self by restrictions that now have been dissolved.", followed by "intensely distressing" nightmares and "metaphysical panic" 4 days later [5]
In a study by Blum et al. (1967), a 23-year-old became psychologically addicted to LSD after regular use of 100 – 300 µg led to states of “mystical consciousness” and religious “illumination”, as he claimed he “wanted to stay there” due to feeling “unusually secure” and overcoming feelings of inferiority [5].
Long-Term Effects Of LSD
Schizophrenic Episodes
Schizophrenic (SCZ) episodes are long-term effects of LSD abuse caused by 5-HT2A receptor hyperfunction in the cerebral cortex, as serotonin levels are 42% higher in SCZ patients compared to non-SCZ patients and increase by a further 2-fold after daily use of LSD [4][15].
LSD use triggers schizophrenic episodes because cortisol levels in SCZ users are 85% higher than in non SCZ users and rise by a further 180 nmol/L within 2.5 hrs of taking 200 µg LSD, and for every 1 (SD) increase in cortisol, the risk of psychosis increases by 17.5 times [1][15][16].
23 – 35% of schizophrenic drug users take LSD and typically experience the first schizophrenic episode 4 years earlier than non-drug using schizophrenics (19 vs 23) as hallucinogen drug abuse increases unusual thought content (e.g. grandiose delusions) and hostility by up to 38% [17][18].
In a study by Turkia (2024), a man with schizoaffective paranoid psychosis consumed 70 μg LSD daily for 1 month, describing the experience as “strange, disorienting, dissociative, like floating in space”, and claiming to feel depressed, ‘cry a lot’, and wanting to “check into a hospital” [19].
Bipolar Episodes
Bipolar episodes are long-term effects of LSD misuse because bipolar patients already experience severe mood swings (mania to depression) due to serotonin imbalances in the brain (e.g. can reduce by 19% within 8 hours), and daily LSD use exacerbates mood fluctuations by reducing 5-HT2A receptor signalling by 36% [12][20].
Up to 71% of daily LSD users feel anxious, extremely agitated, or have “a very low mood” after drug-taking, although 59% feel “back to normal” within 24 hours, symptoms in the 2.6% of past-year LSD users with bipolar disorder (BD) are likely to be intensified because [21]:
Consuming LSD for 5 days depletes 5-HT by up to 36% in the brain regions responsible for mood regulation (e.g. prefrontal cortex), and BD patients with a history of suicide attempts have 32% less 5-HT than BD patients who have never attempted suicide [12][22]
13% of BD users experience a reduction (⩽ −2.82 pts on WEMWBS) in overall wellbeing (e.g. feeling cheerful) within 1 month of LSD use, and 7% already have “challenging, fluctuating, and overwhelming emotions” for up to 3 years after using LSD [11][23]
Individuals with a genetic vulnerability to bipolar disorder and a history of LSD use experience 26% more manic symptoms (e.g. needing less sleep than usual, periods of racing thoughts) compared to non-drug using individuals [24]
Migraines
Migraines and cluster headaches are long-term effects of chronic lysergic acid diethylamide abuse (e.g. >2 times per week for >6 months) caused by:
Sudden drops in serotonin (-36% in the prefrontal cortex) after periods of elevation (2-fold increase within 2 hours of use), leading to the dysregulation of the trigeminal sensory pain pathway and vascular tone [4][12]
“Taking too much” or “Mixing with other drugs”, according to 7% of daily users who seek emergency medical treatment (EMT) due to persistent headaches (>4 weeks) after consuming 50% more LSD within the past year compared to non-EMT seekers [21]
In a study by Ponté et al. (2019), a 34-year-old man experienced cluster headaches 1 – 2 times a week with intense periorbital pain lasting 30 to 60 minutes each time, followed by forehead and facial sweating after regularly using LSD for the last 18 years [25].
In a study by Ponté et al. (2019), a 29-year-old man had 15 – 60-minute cluster headache ‘attacks’ for 5 years and claimed stress was the triggering factor despite using LSD for 14 years, and consuming up to 24 units of alcohol and 30 cigarettes per day [25].
7.4% attempt to self-medicate migraines with LSD, and 25% describe the method as ineffective, despite experiencing an initial relief of symptoms (e.g. watery eyes) after a temporary 5-HT elevation inhibits the trigeminovascular system and constricts blood vessels [26].
Hallucinogen Persisting Perception Disorder
Hallucinogen persisting perception disorder (HPPD) is a long-term effect oflysergic acid diethylamide addiction caused by 5-HT2A receptor desensitisation and disrupted thalamocortical signalling, leading to persistent visual disturbances in 4.2% of users [27].
LSD triggers 30% of HPPD cases in users who begin abusing hallucinogenic drugs at 20 years old, the mean age of symptom onset is 24, and ‘visual snow’ is most common (100%), followed by ‘floaters’ in 62%, and Palinopsia/Photopsia in 54% [28].
In a study by Iaria et al. (2010), a 49-year-old had daily visual hallucinations of ‘unfamiliar’ faces when staring at trees for around 3-7 seconds each time, due to abnormal neural activity in various cortical regions (e.g. fusiform gyrus) after abusing LSD weekly at the age of 21 [29].
Noushad et al. (2015) documented how a 48-year-old man was diagnosed with HPPD after experiencing persistent visual disturbances (e.g. Micropsia, Geometric hallucinations) for 25 years, claiming to be unable to cross the road or read after binging on LSD during his early 20s [8].
25% of patients who develop Hallucinogen persisting perception disorder after abusing LSD fully recover, and 54.2% partially recover after treatment with anti-epileptic drugs (e.g. lamotrigine), SSRIs (e.g. Escitalopram), or antipsychotics (e.g. Risperidone) [28].
LSD Mechanism Of Action
LSD’s mechanism of action involves:
The activation of frontal cortex glutamate transmission, secondary to 5-HT2A receptor stimulation, leading to physiological and psychological effects (e.g. dilated pupils, visual hallucinations) within 1 hour of use, typically lasting for 6 – 12 hours [30]
Binding to 5-HT2A receptors and increasing brain 5-HT levels by 2-fold within 2 hours, followed by the release of dopamine in the striatum and prefrontal cortex after binding to D2 receptors (Receptor binding K = 0.025 μM) and activating the brain’s reward system [4][31]
Who Is More Likely To Develop An LSD Addiction?
More Likely To Develop An LSD Addiction
Why?
Micro-Dosing For Cognitive Enhancement
6.6% microdose to experience positive effects (e.g, stronger functional connectivity between brain regions, i.e. amygdala) = become reliant on LSD to feel “cognitively balanced” [14]
Daily use (e.g. 1x 8-hour “blot”) within 4 weeks of initiation = tolerance develops = stronger doses required (e.g. 3x 16-hour “blot”) within 2 years [32]
Pre-Existing Mental Health Disorders
Used by up to 63% to enhance mental well-being, as some claim “my depression is lifted” after taking 125 μg [5][14]
Use at EDM parties, nightclubs, and dance festivals has increased by 67% within 3 years, and 63% obtain LSD from friends in social settings [14][33]
26% have an ‘intense positive experience’ then associate LSD with ‘having a good time’, encouraging regular use to relive the high [14]
Artists, Musicians, And Creatives
Up to 73% use for personal growth, self-exploration, or "to experience life as a creative process," within 1 hour of using 100μg [5][14]
Enhanced sensory perception encourages regular use as some claim to “see the sounds" of a song and “taste the colour red” in a painting, leading to irrational beliefs (e.g. “I need LSD to compose good music.”) [5]
How LSD Episodes Change In LSD Addiction
LSD episodes change inlysergic acid diethylamide addiction because higher doses (e.g. ≥200 μg) are typically required more frequently (e.g. 3 ‘blots’ daily) after developing a physical tolerance and psychological dependence on the drug, leading to:
Challenging experiences, i.e. “bad trips” in 52%, including mental or sensory overload, social paranoia, and fears of dying, after mainly having “intense positive experiences” that included intense euphoria, pleasure, and feelings of connectedness [14]
Hospital admissions in 55% of past year users who consume an average of 1-2 doses per session, due to extreme agitation or sweating, confusion, paranoia, difficulty breathing, chest pains, or fits/seizures after claiming to have “taken too much” [21]
In a study by Gashi et al. (2021), a man had a ‘bad’ trip that lasted around 4-5 hours after taking “the highest dose I’ve ever taken of LSD”, claiming “I was the most experienced person in the room, and I lay there convinced that I had become psychotic and would never get well again” [34].
In a study by Modak et al. (2019), a 20-year old man with a 2-year history of LSD abuse consumed 3 ‘blots’ daily after being unable to get a ‘trip’ and subsequently experienced severe sweating, palpitations, a fear of death, and vomiting for 2 – 3 hours, despite ‘enjoying the effects’ (e.g. euphoria) during the first month of use [32].
About the author
Mischa Ezekpo
Mischa Ezekpo has a Bachelors degree in Psychology from Northumbria
University, and a Masters degree in Childhood Development and
Wellbeing, from Manchester Metropolitan University. Since 2018, Mischa
has written and published work on Addiction, Mental Health, Depression, and Eating Disorders. Content reviewed by Laura Morris (Clinical Lead).